Results 31 to 40 of about 178,848,266 (217)

Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature

, 2020
In the past, osteonecrosis of the jaw (ONJ) was generally reported with bisphosphonate drugs; hence, the term BRONJ (bisphosphonate-related osteonecrosis of the jaw) was initially proposed.
Bakr, Mahmoud M, Meer, Mohammed, Allauddin Siddiqi, Mahmoud M. Bakr, Nupur Kanwar, Mohammed Meer, Kanwar, Nupur, Siddiqi, Allauddin   +7 more
core   +1 more source

An unusual case of bone regeneration of a necrotic mandible with pathologic fracture in an elderly hemodialysis patient with medication-related osteonecrosis of the jaw: a case report and review of the literature

Journal of Medical Case Reports, 2021
Background Bisphosphonates are frequently used for osteoporosis. Medication-related osteonecrosis of the jaw, a complication of bone-modifying agents, including bisphosphonates or angiogenic inhibitors, can be challenging to treat in elderly patients ...
Kunio Yoshizawa, Akinori Moroi, Ran Iguchi, Akihiro Takayama, Junko Goto, Yutaka Takayama, Koichiro Ueki   +6 more
doaj   +1 more source

Surgical Management of Medication-Related Osteonecrosis of the Jaw Patients Related to Dental Implants [PDF]

, 2020
The aim of the present study is to report a case series of patients with peri-implant medication-related osteonecrosis of the jaw (MRONJ), in particular describing the onset of the condition and surgical treatment ...
Izzetti, Rossana, Graziani, Filippo, Gennai, Stefano, Bellini, Pierantonio, Nisi, Marco, Gabriele, Mario   +5 more
core   +1 more source

Medication‐related osteonecrosis of the jaw: A disease of significant importance for older patients

, 2023
Background: Medication-related osteonecrosis of the jaw (MRONJ) is clinically defined as a non-healing jawbone ulcerative-necrotic lesion appearing after dental therapy or minor trauma in patients treated previously with anti-resorptive, anti-angiogenic ...
Popa-Wagner, Aurel, Bogdan Capitanescu, Bridget Boston, Warnke, Patrick Hans-Heinrich, Michael Hadjiargyrou, Patrick Hans‐Heinrich Warnke, Robert Love, Deepak Ipe, Nusem, Iulian, Love, Robert, Petcu, Eugen Bogdan, Hadjiargyrou, Michael, Hamlet, Stephen, Andrei Gresita, Stephen Hamlet, Ipe, Deepak, Gresita, Andrei, Rodica Ileana Miroiu, Huang, Chien-Ling, Capitanescu, Bogdan, Miroiu, Rodica Ileana, Chien‐Ling Huang, Eugen Bogdan Petcu, Aurel Popa‐Wagner, Boston, Bridget, Iulian Nusem   +25 more
core   +1 more source

A clinical retrospective study of implant as a risk factor for medication-related osteonecrosis of the jaw: surgery vs loading?

Maxillofacial Plastic and Reconstructive Surgery, 2023
Background Risk factors for developing medication-related osteonecrosis of the jaw (MRONJ) include the general condition of the patient, smoking habit, poor oral hygiene, and the type, duration, and administration route of the drug, dentoalveolar surgery,
Yong-Dae Kwon, Hyunmi Jo, Jae-Eun Kim, Joo-Young Ohe   +3 more
doaj   +1 more source

Medication-related Osteonecrosis of the Jaw [PDF]

Radiology, 2021
null Sajeev R. Ezhapilli Chennan, MBBS, null Maria Andrea Parra Corral, MD, null Ronald T. Smith Jr, MD, null Claudia Jordan-Guedes   +3 more
openaire   +3 more sources

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology

Dentistry Journal, 2018
The recent randomized trial, published by Raje et al., on Lancet Oncology is potentially practice changing. It proposes that denosumab is a valid alternative to zoledronic acid in the treatment of myeloma patients.
Vittorio Fusco, Giuseppina Campisi, Paul de Boissieu, Federico Monaco, Anna Baraldi, Gianmauro Numico, Alberto Bedogni   +6 more
doaj   +1 more source

Medication-Related Osteonecrosis of the Jaws (MRONJ): Etiological Update

, 2014
Osteonecrosis of the jaws (ONJ) is an uncommon but severe bone disease, can be related to various medicaments (MRONJ) including bisphosphonates (BRONJ), antiangiogenic and antiresorptive medicaments such as Denosumab (DRONJ), human monoclonal antibody to
TENORE, GIANLUCA, ROMEO, Umberto, GAIMARI, GIANFRANCO, Gianfranco Gaimari, Orlando Brugnoletti, Mohamed Mohsen, BRUGNOLETTI, Orlando, Gianluca Tenore, BOVE, Ercole, PALAIA, GASPARE, Lino Bove, Rossella Lo Giudice, Gaspare Palaia, Umberto Romeo   +13 more
core   +1 more source

Therapeutic Effect of Benidipine on Medication-Related Osteonecrosis of the Jaw

Pharmaceuticals, 2022
Medication-related osteonecrosis of the jaw (MRONJ) is an intractable disease that is typically observed in patients with osteoporosis or tumors that have been treated with either bisphosphonate (BP) or antiangiogenic medicine.
Ken Matsunaka, Mikio Imai, Koma Sanda, Noriyuki Yasunami, Akihiro Furuhashi, Ikiru Atsuta, Hiroko Wada, Yasunori Ayukawa   +7 more
doaj   +1 more source

Medication Related Osteonecrosis of the Jaw: Knowledge, Attitudes and Practice Patterns Among Australian Dental Practitioners

Australian Dental Journal, EarlyView.
ABSTRACT Background Medication related osteonecrosis of the jaw (MRONJ) is a debilitating condition associated with antiresorptive and antiangiogenic therapies. As the use of these medications continues to increase, dental practitioners play a critical role in prevention and management of at‐risk patients. This survey evaluated the awareness, knowledge
Ying Shi Chang, Christopher Friel, Gary Low, Albert Yaacoub, Stephen Clive Cox   +4 more
wiley   +1 more source